Peripheral blood mononuclear cell transcriptomic trajectories reveal dynamic regulation of inflammatory actors in delirium.

Sara C LaHue, Naoki Takegami, Rubinee Simmasalam, Abiya Baqai, Elena Munoz, Anya Sikri, Thibault du Buisson de Courson, Nilika S Singhal, Walter Eckalbar, Charles R Langelier, Carolyn M Hendrickson, Carolyn S Calfee, David J Erle, Matthew F Krummel, Prescott G Woodruff, Tomiko Oskotsky, Marina Sirota, Adam Ferguson, Vanja C Douglas, John C Newman, Samuel J Pleasure, Michael R Wilson, COMET consortium, Neel S Singhal
Author Information
  1. Sara C LaHue: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  2. Naoki Takegami: Weill Institute for Neurosciences, UCSF.
  3. Rubinee Simmasalam: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  4. Abiya Baqai: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  5. Elena Munoz: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  6. Anya Sikri: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  7. Thibault du Buisson de Courson: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  8. Nilika S Singhal: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  9. Walter Eckalbar: Department of Medicine, UCSF.
  10. Charles R Langelier: Division of Infectious Diseases, UCSF.
  11. Carolyn M Hendrickson: Department of Medicine, UCSF.
  12. Carolyn S Calfee: Department of Medicine, UCSF.
  13. David J Erle: Department of Medicine, UCSF.
  14. Matthew F Krummel: UCSF CoLabs, UCSF.
  15. Prescott G Woodruff: Department of Medicine, UCSF.
  16. Tomiko Oskotsky: Bakar Computational Health Sciences Institute, UCSF. ORCID
  17. Marina Sirota: Bakar Computational Health Sciences Institute, UCSF.
  18. Adam Ferguson: Weill Institute for Neurosciences, UCSF.
  19. Vanja C Douglas: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  20. John C Newman: Buck Institute for Research on Aging, Novato, USA. ORCID
  21. Samuel J Pleasure: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA.
  22. Michael R Wilson: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA. ORCID
  23. Neel S Singhal: Department of Neurology, School of Medicine, University of California-San Francisco (UCSF), USA. ORCID

Abstract

Delirium is a neurologic syndrome characterized by inattention and cognitive impairment frequently encountered in the medically ill. Peripheral inflammation is a key trigger of delirium, but the patient-specific immune responses associated with delirium development and resolution are unknown. This retrospective cohort study of prospectively collected biospecimens examines RNA sequencing from peripheral blood mononuclear cells of adults hospitalized for COVID-19 to better understand patient-specific factors associated with delirium (n = 64). Longitudinal transcriptomic analyses highlight persistent immune dysregulation in delirium, marked by increasing expression trajectories of genes linked to innate immune pathways, including complement activation, cytokine production, and monocyte/macrophage recruitment. Genes involved adaptive immunity showed a declining trajectory over time in patients with delirium. Although corticosteroid treatment suppressed some aspects of immune hyperactivation, aberrant responses contributing to delirium were exacerbated. Delirium resolution was characterized by normalization of key transcripts such as and innate immune markers. Novel associations with delirium were found in genes related to stress granule assembly and and , which mediate T-cell responses. These findings provide insights into the peripheral immune responses accompanying delirium and their modulation by corticosteroids. Future trials targeting aberrant inflammatory responses may mitigate the severe outcomes associated with delirium due to COVID19.

References

  1. Anesthesiology. 2019 Sep;131(3):477-491 [PMID: 31166241]
  2. J Am Geriatr Soc. 2003 May;51(5):591-8 [PMID: 12752832]
  3. J Hosp Med. 2021 Jul;16(7):397-403 [PMID: 34197303]
  4. BMC Psychiatry. 2022 Feb 28;22(1):151 [PMID: 35227231]
  5. Mol Med. 2009 Nov-Dec;15(11-12):384-91 [PMID: 19750196]
  6. N Engl J Med. 2018 Jan 4;378(1):96-97 [PMID: 29298149]
  7. J Leukoc Biol. 2010 Dec;88(6):1207-16 [PMID: 20884650]
  8. Gerontology. 2023;69(12):1369-1384 [PMID: 37722373]
  9. BMC Bioinformatics. 2008 Dec 29;9:559 [PMID: 19114008]
  10. Cell Rep. 2019 Feb 5;26(6):1627-1640.e7 [PMID: 30726743]
  11. Cell Rep. 2021 Mar 16;34(11):108863 [PMID: 33691089]
  12. J Am Geriatr Soc. 2020 Aug;68(8):1864-1871 [PMID: 32531089]
  13. Genome Biol. 2014;15(12):550 [PMID: 25516281]
  14. Nat Rev Immunol. 2017 Oct;17(10):647-660 [PMID: 28669985]
  15. Ann Neurol. 2023 Dec;94(6):1024-1035 [PMID: 37615660]
  16. Nat Immunol. 2018 Sep;19(9):954-962 [PMID: 30127438]
  17. BMC Geriatr. 2022 Mar 14;22(1):200 [PMID: 35287583]
  18. Nucleic Acids Res. 2015 Apr 20;43(7):e47 [PMID: 25605792]
  19. Crit Care Med. 2018 Dec;46(12):2029-2035 [PMID: 30234569]
  20. Lancet Respir Med. 2021 Mar;9(3):239-250 [PMID: 33428871]
  21. Crit Care. 2011;15(6):R297 [PMID: 22206727]
  22. Nat Rev Immunol. 2020 Oct;20(10):587-588 [PMID: 32778829]
  23. Crit Care. 2020 Aug 8;24(1):491 [PMID: 32771053]
  24. Nat Immunol. 2015 Dec;16(12):1263-73 [PMID: 26479789]
  25. Ann Neurol. 2024 Jul;96(1):74-86 [PMID: 38501714]
  26. JAMA Intern Med. 2015 Apr;175(4):512-20 [PMID: 25643002]
  27. JAMA Netw Open. 2023 Jan 3;6(1):e2249950 [PMID: 36607634]
  28. BMC Bioinformatics. 2018 Dec 19;19(1):534 [PMID: 30567491]
  29. Int Immunopharmacol. 2021 Sep;98:107906 [PMID: 34198238]
  30. Int J Geriatr Psychiatry. 2018 Nov;33(11):1428-1457 [PMID: 29278283]
  31. Nucleic Acids Res. 1995 Dec 11;23(23):4907-12 [PMID: 8532536]
  32. Nat Immunol. 2020 Mar;21(3):287-297 [PMID: 31932812]
  33. Blood. 2010 Nov 25;116(22):4404-14 [PMID: 20616217]
  34. EBioMedicine. 2015 Oct 03;2(11):1785-98 [PMID: 26870803]
  35. Eur Geriatr Med. 2020 Oct;11(5):857-862 [PMID: 32666303]
  36. Nucleic Acids Res. 2023 Jul 5;51(W1):W168-W179 [PMID: 37166973]
  37. Cell Rep. 2019 Jan 2;26(1):94-107.e7 [PMID: 30605689]
  38. Cells. 2021 Aug 28;10(9): [PMID: 34571877]

Grants

  1. R01 NS125693/NINDS NIH HHS
  2. U19 AI077439/NIAID NIH HHS

Word Cloud

Created with Highcharts 10.0.0deliriumimmuneresponsesassociatedDeliriumcharacterizedPeripheralkeypatient-specificresolutionperipheralbloodmononucleartranscriptomictrajectoriesgenesinnateaberrantinflammatoryneurologicsyndromeinattentioncognitiveimpairmentfrequentlyencounteredmedicallyillinflammationtriggerdevelopmentunknownretrospectivecohortstudyprospectivelycollectedbiospecimensexaminesRNAsequencingcellsadultshospitalizedCOVID-19betterunderstandfactorsn=64Longitudinalanalyseshighlightpersistentdysregulationmarkedincreasingexpressionlinkedpathwaysincludingcomplementactivationcytokineproductionmonocyte/macrophagerecruitmentGenesinvolvedadaptiveimmunityshoweddecliningtrajectorytimepatientsAlthoughcorticosteroidtreatmentsuppressedaspectshyperactivationcontributingexacerbatednormalizationtranscriptsmarkersNovelassociationsfoundrelatedstressgranuleassemblymediateT-cellfindingsprovideinsightsaccompanyingmodulationcorticosteroidsFuturetrialstargetingmaymitigatesevereoutcomesdueCOVID19cellrevealdynamicregulationactors

Similar Articles

Cited By